The Merlin test categorises melanoma patients by sentinel lymph node (SLN) metastasis risk, aiding effective risk-based ...

By Karen Roman Diagnostics company SkylineDx said it will present clinical data on the success of its Merlin test at the 21st ...

The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, significantly reduces the need for sentinel ...

(MENAFN- PR Newswire) ROTTERDAM, Netherlands and SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular ...

Paid and presented by SkylineDX. The advent of precision medicine is a defining moment for healthcare, making personalised patient care a reality. Jenny was diagnosed with multiple myeloma 10 ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

The Centurion Condominium, located in Midtown New York near Central Park, and designed by legendary... at 11:40 SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene Expression ...

SkylineDx, a biotech company, has announced new findings from the MERLIN_001 clinical trial of melanoma genomic assay, Merlin test, in the US. The trial has validated the Clinical-Pathologic and ...

ROTTERDAM, Netherlands and SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, ...